Drug Shortage Report for PMS-SIMVASTATIN

Last updated on 2020-06-10 History
Report ID 37340
Drug Identification Number 02269279
Brand name PMS-SIMVASTATIN
Common or Proper name SIMVASTATIN
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) SIMVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-24
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469995)
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-06-10 French Compare
v5 2020-06-10 English Compare
v4 2018-02-15 French Compare
v3 2018-02-15 English Compare
v2 2018-01-26 French Compare
v1 2018-01-26 English Compare

Showing 1 to 6 of 6